Charlestrad3r

Looking to buy the dip

看多
NASDAQ:CTXR   Citius Pharmaceuticals, Inc.
Citius recently Announced Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial
Top line data due for 1H 2020
insider Own 42.50%
Shs Float 16.64M
Market Cap 28.70M
Increase in hedge fund holdings

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。